Key Points: Ultherapy targets deep structural layers of the face to improve jawline definition, but skin surface concerns like enlarged pores and excess sebum require a different approach entirely. Combining Ultherapy PRIME with Microbotox (skin botox) addresses both deep tissue laxity and surface texture issues, which may help explain why some patients feel unsatisfied after lifting treatments alone.
Why Do Some Patients Feel Unsatisfied After Ultherapy?
One of the most common concerns heard during consultations is this: 'I had a lifting treatment, but something still feels off.' Many patients who undergo Ultherapy notice an improvement in their jawline, yet feel the overall result is not quite what they had hoped for. This experience is more common than many realize, and it often comes down to a mismatch between what was treated and what was actually causing the concern.
Facial aging is not driven by tissue sagging alone. The surface condition of the skin — including sebum overproduction, enlarged or elongated pores, and fine textural irregularities — plays a significant role in how the face looks and how fresh or fatigued it appears. When these surface-level factors are not addressed alongside deeper structural work, the face can look lifted in contour but still appear dull, rough, or uneven in texture.
This is precisely the situation a patient at our Songpa-gu clinic described. She had received Ultherapy the previous year, noticed her jawline had improved, yet found it difficult to articulate why she still felt disappointed. After a closer consultation under bright lighting, it became clear that excess sebum and vertically stretched pores across her cheeks were contributing to her dissatisfaction — a layer that Ultherapy, by design, does not target.
What Does Ultherapy Actually Treat — and What Are Its Limits?
Ultherapy delivers focused ultrasound energy to the SMAS layer (superficial musculoaponeurotic system), the deep structural layer beneath the skin responsible for facial support. When this layer weakens over time, the face begins to sag and contours soften. By delivering heat precisely to this depth, Ultherapy can help tighten the SMAS layer, and as new collagen gradually forms in response, lifting effects may develop over approximately two to three months following treatment.
Because Ultherapy works at this deeper structural level, it is well suited for concerns like a blurred jawline, sagging cheeks, or loss of facial definition. However, it is not designed to address what sits at the very surface of the skin — sebum production, pore size, or fine surface lines. These are different anatomical concerns that exist in a shallower layer entirely.
The clinical implication is important: even with an excellent lifting outcome, skin that reflects light unevenly due to excess sebum, or that shows visible shadows from stretched pores, can still look tired or aged. No amount of deep tissue tightening changes the behavior of sebaceous glands or pore structure. If the surface is not also addressed, the result may feel incomplete — not because the lifting failed, but because the full picture of the concern was only partially treated.
Understanding this distinction helps patients ask a more precise question before choosing a treatment: which layer is most responsible for what is bothering me right now?
How Does Ultherapy PRIME Differ from Standard Ultherapy?
Ultherapy PRIME is the latest generation of the Ultherapy platform, featuring improved ultrasound imaging resolution compared to earlier versions. This enhanced visualization allows the treating physician to more clearly identify skin layer boundaries in real time, enabling more precise depth adjustments during the procedure.
During treatment, the ultrasound imaging screen shows the exact depth at which energy is being delivered. With higher image clarity, it becomes possible to vary the depth settings more accurately across different facial zones — which matters because facial anatomy varies from area to area. The jawline, under-chin region, and cheek each have different tissue thicknesses and structural characteristics.
For this patient, treatment was focused on the jawline and under-chin area, with careful real-time monitoring throughout. Topical anesthetic cream was applied approximately thirty minutes prior to allow for a more comfortable experience. The ability to confirm layer placement visually before each shot is one of the features that distinguishes Ultherapy PRIME in terms of precision.
How Does Microbotox Address What Ultherapy Cannot?
Microbotox — also known as skin botox or mesobotox — involves injecting very small amounts of botulinum toxin into the superficial dermal layer at multiple points across the face. Unlike standard Botox injections that target muscle movement, Microbotox is specifically designed to work at the skin surface level, helping to reduce sebum secretion, minimize the appearance of pores, and smooth fine surface texture.
Because sebaceous glands and pore openings are concentrated unevenly across the face — typically more active around the forehead and nose, and relatively less so at the cheeks and jawline — a uniform injection approach across the entire face may over-treat some areas while under-treating others. A more individualized distribution, with amounts adjusted by zone based on each patient's specific sebum pattern and pore condition, tends to produce a more balanced surface result.
In this patient's case, her cheeks showed noticeably greater sebum activity and more prominent pore elongation than other areas of her face. Microbotox was administered after the Ultherapy PRIME session, with a slightly higher concentration directed toward the cheek zone. When she returned approximately three months later, she described the experience as clearly different from her previous treatment — not just a lifted jawline, but a more overall refined and refreshed appearance. The combination of deep structural correction and surface texture treatment had addressed both layers contributing to her concern.
It is worth noting that individual responses to both Ultherapy and Microbotox vary, and outcomes depend on factors including skin condition, age, and treatment history. These treatments are not guaranteed to produce a specific result, and a thorough consultation is important before deciding on any combination approach.
What Should You Consider Before Choosing a Lifting Treatment?
Before selecting a lifting treatment — or deciding whether to repeat one — it is worth identifying which layer of the face is most responsible for the concern. Sagging, loss of jawline definition, and descent of cheek tissue originate in the deeper structural layers and are best addressed by energy-based lifting devices like Ultherapy. Shininess, visible pores, and surface roughness originate at the skin's superficial level and require a different kind of intervention.
If a previous lifting treatment left you feeling that something was still missing, the issue may not have been the number of shots delivered or the device used — it may simply have been that only one layer was treated when both needed attention. This does not mean more is always better; it means that the right treatment needs to match the right concern at the right depth.
A good consultation should include a close look at your skin surface under adequate lighting, not just an assessment of facial contour and tissue descent. This makes it possible to map out concerns more completely and propose a plan that is honest about what each treatment can and cannot achieve. At Sunshine Dermatology Clinic, only treatments considered genuinely necessary for each individual patient are recommended.
Frequently Asked Questions
Why did my Ultherapy results feel underwhelming even though my jawline improved?
Ultherapy works at a deep structural layer called the SMAS layer to lift and tighten sagging tissue. However, surface concerns like enlarged pores and excess sebum — which also affect how the face looks — are not within the scope of what Ultherapy treats. If these surface factors were not addressed separately, you may notice a lifted contour but still feel the overall result is incomplete. A combined approach targeting both layers may better reflect the full change you were expecting.
What is Microbotox and how is it different from regular Botox?
Microbotox (also called skin botox or mesobotox) involves injecting very small amounts of botulinum toxin into the superficial layer of the skin — not into the muscles. Its primary effects are on the skin surface: reducing sebum production, minimizing pore appearance, and smoothing fine texture. Regular Botox is injected deeper into specific muscles to reduce movement and expression lines. The two approaches serve different purposes and can be used together.
How long does it take to see results from Ultherapy PRIME?
Ultherapy works by stimulating collagen remodeling in the deep tissue layers. Because this is a gradual biological process, results typically develop over approximately two to three months following treatment rather than appearing immediately. Individual timelines and outcomes can vary depending on skin condition, age, and other factors.
Is it safe to combine Ultherapy PRIME and Microbotox in the same session?
These two treatments target entirely different depths of tissue — Ultherapy at the deep SMAS layer and Microbotox at the superficial dermal layer — so they do not interfere with each other mechanically. Whether combining them in a single session is appropriate depends on each patient's overall skin condition and health history. A proper consultation is necessary to assess suitability before proceeding with any combined treatment plan.
Should I repeat Ultherapy, or is a different treatment needed?
If your previous Ultherapy produced some improvement but left you feeling unsatisfied, repeating the same treatment alone may not fully resolve the issue. It is worth considering whether surface-level concerns — such as pores, sebum, or skin texture — were also contributing to the appearance you wanted to improve. Identifying which layer your concern originates from is an important first step before deciding whether to repeat a treatment or add a complementary one.